Structural Requisites of 2-(p-chlorophenoxy)propionic Acid Analogues for Activity on Native Rat Skeletal Muscle Chloride Conductance and on Heterologously Expressed CLC-1
Overview
Authors
Affiliations
(1) The 2-(p-chlorophenoxy)propionic acid (CPP) modulates in a stereoselective manner the macroscopic chloride conductance (gCl), the electrical parameter sustained by the CLC-1 channel, of skeletal muscle. In order to determine the structural requirements for modulating native gCl and to identify high-affinity ligands, the effects of newly synthesised CPP analogues have been evaluated on gCl of rat EDL muscle fibres by means of the two-microelectrode current-clamp technique. (2) Each type of the following independent modification of CPP structure led to a three- to 10-fold decrease or to a complete lack of gCl-blocking activity: replacement of the electron-attractive chlorine atom of the aromatic ring, substitution of the oxygen atom of the phenoxy group, modification at the chiral centre and substitution of the carboxylic function with a phosphonate one. (3) The analogues bearing a second chlorophenoxy group on the asymmetric carbon atom showed a significant gCl-blocking activity. Similar to racemate CPP, the analogue with this group, spaced by an alkyl chain formed by three methylenic groups, blocked gCl by 45% at 100 micro M. (4) These latter derivatives were tested on heterelogously expressed CLC-1 performing inside-out patch-clamp recordings to further define how interaction between drug and channel protein could take place. Depending on the exact chemical nature of modification, these derivatives strongly blocked CLC-1 with K(D) values at -140 mV ranging from about 4 to 180 micro M. (5) In conclusion, we identified four molecular determinants pivotal for the interaction with the binding site on muscle CLC-1 channels: (a) the carboxylic group that confers the optimal acidity and the negative charge; (b) the chlorophenoxy moiety that might interact with a hydrophobic pocket; (c) the chiral centre that allows the proper spatial disposition of the molecule; (d) an additional phenoxy group that remarkably stabilises the binding by interacting with a second hydrophobic pocket.
Coppola M, Pusch M, Imbrici P, Liantonio A Biomolecules. 2023; 13(4).
PMID: 37189456 PMC: 10135884. DOI: 10.3390/biom13040710.
Clues and new evidences in arterial hypertension: unmasking the role of the chloride anion.
Kouyoumdzian N, Kim G, Rudi M, Rukavina Mikusic N, Fernandez B, Choi M Pflugers Arch. 2021; 474(1):155-176.
PMID: 34966955 DOI: 10.1007/s00424-021-02649-5.
Altamura C, Mangiatordi G, Nicolotti O, Sahbani D, Farinato A, Leonetti F Br J Pharmacol. 2018; 175(10):1770-1780.
PMID: 29500929 PMC: 5913395. DOI: 10.1111/bph.14192.
Pierno S, Camerino G, Cippone V, Rolland J, Desaphy J, De Luca A Br J Pharmacol. 2009; 156(8):1206-15.
PMID: 19220292 PMC: 2697730. DOI: 10.1111/j.1476-5381.2008.00079.x.
Blocking pore-open mutants of CLC-0 by amphiphilic blockers.
Zhang X, Tseng P, Yu W, Chen T J Gen Physiol. 2008; 133(1):43-58.
PMID: 19088381 PMC: 2606940. DOI: 10.1085/jgp.200810004.